Literature DB >> 9372205

Down-regulation of the amyloid protein precursor of Alzheimer's disease by antisense oligonucleotides reduces neuronal adhesion to specific substrata.

E J Coulson1, G L Barrett, E Storey, P F Bartlett, K Beyreuther, C L Masters.   

Abstract

The hallmark of Alzheimer's disease is the cerebral deposition of amyloid which is derived from the amyloid precursor protein (APP). The function of APP is unknown but there is increasing evidence for the role of APP in cell-cell and/or cell-matrix interactions. Primary cultures of murine neurons were treated with antisense oligonucleotides to down-regulate APP. This paper presents evidence that APP mediates a substrate-specific interaction between neurons and extracellular matrix components collagen type I, laminin and heparan sulphate proteoglycan but not fibronectin or poly-L-lysine. It remains to be determined whether this effect is the direct result of APP-matrix interactions, or whether an intermediatry pathway is involved.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9372205     DOI: 10.1016/s0006-8993(97)00757-9

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  11 in total

1.  APP and APLP1 are degraded through autophagy in response to proteasome inhibition in neuronal cells.

Authors:  Fangfang Zhou; Theo van Laar; Huizhe Huang; Long Zhang
Journal:  Protein Cell       Date:  2011-05-28       Impact factor: 14.870

Review 2.  Beta-amyloid and cholinergic neurons.

Authors:  Vladimír Dolezal; Jana Kasparová
Journal:  Neurochem Res       Date:  2003-04       Impact factor: 3.996

Review 3.  Presenilins and APP in neuritic and synaptic plasticity: implications for the pathogenesis of Alzheimer's disease.

Authors:  Sic L Chan; Katsutoshi Furukawa; Mark P Mattson
Journal:  Neuromolecular Med       Date:  2002       Impact factor: 3.843

4.  c-Jun N-terminal kinase (JNK)-interacting protein-1b/islet-brain-1 scaffolds Alzheimer's amyloid precursor protein with JNK.

Authors:  S Matsuda; T Yasukawa; Y Homma; Y Ito; T Niikura; T Hiraki; S Hirai; S Ohno; Y Kita; M Kawasumi; K Kouyama; T Yamamoto; J M Kyriakis; I Nishimoto
Journal:  J Neurosci       Date:  2001-09-01       Impact factor: 6.167

5.  Antisense inhibition at the beta-secretase-site of beta-amyloid precursor protein reduces cerebral amyloid and acetyl cholinesterase activity in Tg2576.

Authors:  Neelima B Chauhan; George J Siegel
Journal:  Neuroscience       Date:  2007-02-14       Impact factor: 3.590

Review 6.  The many substrates of presenilin/γ-secretase.

Authors:  Annakaisa Haapasalo; Dora M Kovacs
Journal:  J Alzheimers Dis       Date:  2011       Impact factor: 4.472

7.  Dosage of amyloid precursor protein affects axonal contact guidance in Down syndrome.

Authors:  Lucas J Sosa; Nienke L Postma; Adriana Estrada-Bernal; M Hanna; R Guo; Jorge Busciglio; Karl H Pfenninger
Journal:  FASEB J       Date:  2013-09-13       Impact factor: 5.191

Review 8.  Antisense Drugs Make Sense for Neurological Diseases.

Authors:  C Frank Bennett; Holly B Kordasiewicz; Don W Cleveland
Journal:  Annu Rev Pharmacol Toxicol       Date:  2020-10-09       Impact factor: 13.820

9.  Mutant Presenilin 1 Dysregulates Exosomal Proteome Cargo Produced by Human-Induced Pluripotent Stem Cell Neurons.

Authors:  Sonia Podvin; Alexander Jones; Qing Liu; Brent Aulston; Charles Mosier; Janneca Ames; Charisse Winston; Christopher B Lietz; Zhenze Jiang; Anthony J O'Donoghue; Tsuneya Ikezu; Robert A Rissman; Shauna H Yuan; Vivian Hook
Journal:  ACS Omega       Date:  2021-05-13

10.  Amyloid precursor protein is an autonomous growth cone adhesion molecule engaged in contact guidance.

Authors:  Lucas J Sosa; Jared Bergman; Adriana Estrada-Bernal; Thomas J Glorioso; John M Kittelson; Karl H Pfenninger
Journal:  PLoS One       Date:  2013-05-14       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.